2. Cell Cycle/DNA Damage
  3. CDK
  4. Palbociclib isethionate

Palbociclib isethionate  (Synonyms: 帕博西尼羟乙基磺酸盐; PD 0332991 isethionate)

目录号: HY-A0065 纯度: 99.99%
COA 产品使用指南

摩尔计算器

Palbociclib (PD 0332991) isethionate 是一种具有口服活性的 CDK4 和 CDK6 选择性抑制剂，IC50 值分别为 11 nM 和16 nM。Palbociclib dihydrochloride 对癌细胞具有抗增殖活性，并诱导其细胞周期阻滞，可用于 HR 阳性和 HER2 阴性乳腺癌，以及肝细胞癌的相关研究。

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

Palbociclib isethionate Chemical Structure

Palbociclib isethionate Chemical Structure

CAS No. : 827022-33-3

1.  客户无需承担相应的运输费用。

2.  同一机构（单位）同一产品试用装仅限申领一次，同一机构（单位）一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户。

规格 价格 是否有货 数量
10 mM * 1 mL in DMSO ￥760
In-stock
1 mg ￥250
In-stock
5 mg ￥550
In-stock
10 mg ￥800
In-stock
50 mg ￥1620
In-stock
100 mg ￥2340
In-stock
200 mg ￥2880
In-stock
500 mg ￥5940
In-stock
1 g   询价  
5 g   询价  

* Please select Quantity before adding items.

Customer Review

Other Forms of Palbociclib isethionate:

Palbociclib isethionate 相关抗体

Top Publications Citing Use of Products

MCE 顾客使用本产品发表的 157 篇科研文献

WB
IHC
IF

    Palbociclib isethionate purchased from MCE. Usage Cited in: Life Sciences. 2023 Apr 1, 121652.

    Palbociclib (1 µM; 48 h) decreases the expression of PPARγ in SVFs.

    Palbociclib isethionate purchased from MCE. Usage Cited in: EBioMedicine. 2019 May;43:225-237.  [Abstract]

    Representative images of immunohistochemical staining for proteins as indicated in A2780 xenografted tumors (n=6 per treatment group) treated with AZD2281 and Palbociclib either as single-agents or in combination for 4 days.

    Palbociclib isethionate purchased from MCE. Usage Cited in: Nat Commun. 2018 Oct 9;9(1):4180.  [Abstract]

    MCF7, MCF7-LEM4, and MCF7-TAMR cells are treated with 5% DCC-FBS (vehicle), 4-OHT (1 μM), PD0332991 (PD) (0.2 μM), or a combination of 4-OHT and PD0332991. Immunoblots of lysates from cells are tested.

    Palbociclib isethionate purchased from MCE. Usage Cited in: J Exp Clin Cancer Res. 2018 Sep 20;37(1):233.  [Abstract]

    Western blot of the nine cell cycle-related proteins in C666-1 cells treated with different concentrations of GEM (0.1, 1, and 10 μM) and PAL (0.1, 1, and 5 μM) after 48 h.

    Palbociclib isethionate purchased from MCE. Usage Cited in: Eur J Cancer. 2018 Oct;102:10-22.  [Abstract]

    Head-to-head comparison of the effect of Palbociclib and Ribociclib on DNA damage response (DDR) signalling in liver cancer cells.

    Palbociclib isethionate purchased from MCE. Usage Cited in: Nature. 2017 Jun 15;546(7658):426-430.  [Abstract]

    In vitro kinase reactions using immunoprecipitated endogenous CDK6 and recombinant PFKP or PKM2 with or without Palbociclib (PALBO). 32P-PFKP and 32P-PKM2 denote phosphorylated proteins, IB, immunoblotting.

    Palbociclib isethionate purchased from MCE. Usage Cited in: Mol Oncol. 2017 Aug;11(8):1035-1049.  [Abstract]

    Effects of Palbociclib on CDK4/6-Rb pathway. HCC cells are treated with different doses of Palbociclib for 24 h, and then, the cells are subjected to western blot analysis.

    Palbociclib isethionate purchased from MCE. Usage Cited in: Mol Oncol. 2017 Aug;11(8):1035-1049.  [Abstract]

    Effects of CDK4/6 inhibitors on AMPK phosphorylation and apoptosis-related signals. After 24 h of drug treatment, the cells are subjected to western blot analysis. AMPK phosphorylation level is quantified by the ratio of band intensities of phospho-AMPKα vs. AMPKα.

    Palbociclib isethionate purchased from MCE. Usage Cited in: Mol Oncol. 2017 Aug;11(8):1035-1049.  [Abstract]

    Inhibition of AMPK reverses Palbociclib-induced autophagy and apoptosis. Hep3B cells are incubated with AMPK inhibitor (Compound C, 2.5 μM) for 4 h and then treated with Palbociclib for 24 h. Apoptotic cells are determined by flow cytometry.

    Palbociclib isethionate purchased from MCE. Usage Cited in: Biochim Biophys Acta. 2017 Nov 20;1865(2):354-363.  [Abstract]

    LAPC-4 cells are grown in charcoal-stripped serum medium (CSS) for 24 hours and then stimulated by R1881 alone or with different doses of Palbociclib (PD). Palbociclib is added 30 min before androgen treatment. Cellular expression of all proteins is detected by immunoblotting analysis. β-actin is included as a control for protein loading.

    查看 CDK 亚型特异性产品:

    查看所有亚型
    CDK1 CDK2 CDK3 CDK4 CDK5 CDK6 CDK7 CDK8 CDK9 CDK11 CDK12 CDK13 CDK14 CDK16 CDK19 CDC CLK Pho85

    • 生物活性

    • 纯度 & 产品资料

    • 参考文献

    生物活性

    Palbociclib (PD 0332991) isethionate is an orally active selective CDK4 and CDK6 inhibitor with IC50 values of 11 and 16 nM, respectively. Palbociclib isethionate has potent anti-proliferative activity and induces cell cycle arrest in cancer cells, which can be used in the research of HR-positive and HER2-negative breast cancer and hepatocellular carcinoma[1][3][4].

    IC50 & Target[1]

    Cdk4/cyclin D3

    9 nM (IC50)

    Cdk4/cyclin D1

    11 nM (IC50)

    Cdk6/cyclin D2

    16 nM (IC50)

    DYRK1A

    2000 nM (IC50)

    MAPK

    8000 nM (IC50)

    体外研究
    (In Vitro)

    Palbociclib isethionate dihydrochloride (0-1 μM，24 h) 抑制 MDA-MB-435 细胞中 Ser795 位点的 Rb 磷酸化，IC50 值为 0.063 μM，并获得类似的结果对 Colo -205 结肠癌中 Ser780 和 Ser795 磷酸化的影响[1]。
    Palbociclib isethionate dihydrochloride (0-10 μM，24 小时) 仅在 G1 期阻止 MDA-MB-453 细胞[1]。
    Palbociclib isethionate dihydrochloride (500 nM，7 天) 增加同源基因的表达 (H2d1、H2k1，和 B2m) 在 MDA-MB-453 和 MDA-MB-361 细胞中[2]。
    Palbociclib isethionate dihydrochloride (0-1 μM，6 天) 抑制几种管腔 ER-阳性和 HER2 扩增的乳腺癌细胞系，IC50 值范围为 4 nM-1 μM[3]。
    Palbociclib isethionate dihydrochloride (0-1 μM，3 天) 抑制人肝癌细胞系的增殖，IC50 值范围为 0.01 μM 至 3.49 μM，并诱导可逆的细胞周期停滞[4]。

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Palbociclib isethionate 相关抗体:

    Cell Cycle Analysis[1]

    Cell Line: MDA-MB-453 cells
    Concentration: 0-1 μM
    Incubation Time: 24 h
    Result: Arrested MDA-MB-453 cells in G1.

    Cell Proliferation Assay[3]

    Cell Line: ER-positive as well as HER2-amplified breast cancer cell lines (MDA-MB-175, ZR-75-30, CAMA-1, etc.)
    Concentration: 0-10 μM
    Incubation Time: 6 days
    Result: Inhibited growth of luminal ER-positive as well as HER2-amplified breast cancer cell lines.
    体内研究
    (In Vivo)

    Palbociclib isethionate isethionate (口服，75 或 150 mg/kg，每日一次，持续 14 天) 可使肿瘤快速消退并延缓肿瘤生长[1]。
    Palbociclib isethionate isethionate (口服，90 mg/kg kg，每日一次，持续 12 天) 减少无肿瘤小鼠脾脏和淋巴结中的 Treg 数量和 Treg：CD8 比率，证明了肿瘤非依赖性效应[2]。
    Palbociclib isethionate isethionate (口服给药，100 mg/kg，每日一次，持续 1 周) 在肝癌基因工程镶嵌小鼠模型中具有有效的抗肿瘤作用[4]。

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: Mice bearing Colo-205 colon carcinoma xenografts (p16 deleted)[1]
    Dosage: 75, 150 mg/kg, daily for 14 days
    Administration: Oral adminstration
    Result: Produced rapid tumor regressions and a corresponding tumor growth delay of ~50 days.
    Animal Model: Tumor-free female FVB mice[2]
    Dosage: 90 mg/kg (diluted in 50 nM sodium D-lactate), daily for 12 days
    Administration: Oral adminstration
    Result: Reduced total thymic mass and immature CD4+ and CD8+ double-positive thymocytes, and increased the fractions of CD4+ and CD8+ single-positive thymocytes.
    Animal Model: Genetically engineered mosaic mouse model of liver cancer (Myc;p53-sgRNA)[4]
    Dosage: 100 mg/kg, daily for 1 week.
    Administration: Oral adminstration
    Result: Decreased the luminescence signal in liver and delayed tumour growth.
    Clinical Trial
    分子量

    573.66

    Formula

    C26H35N7O6S
    CAS 号
    性状

    固体

    颜色

    Light yellow to yellow

    中文名称

    帕布昔利布杂质74
    运输条件

    Room temperature in continental US; may vary elsewhere.
    储存方式

    4°C, sealed storage, away from moisture

    *In solvent : -80°C, 1 year; -20°C, 6 months (sealed storage, away from moisture)

    溶解性数据
    细胞实验： 

    H2O 中的溶解度 : 50 mg/mL (87.16 mM; 超声助溶)

    DMSO 中的溶解度 : 10 mg/mL (17.43 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响，请使用新开封的 DMSO)

    配制储备液
    浓度 溶剂体积 质量 1 mg 5 mg 10 mg
    1 mM 1.7432 mL 8.7160 mL 17.4319 mL
    5 mM 0.3486 mL 1.7432 mL 3.4864 mL
    查看完整储备液配制表

    * 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
    储备液的保存方式和期限：-80°C, 1 year; -20°C, 6 months (sealed storage, away from moisture)。-80°C储存时，请在1年内使用， -20°C储存时，请在6个月内使用。

    * 备注：如您选择水作为储备液，请稀释至工作液后，再用 0.22 μm 的滤膜过滤除菌后使用。

    • 摩尔计算器

    • 稀释计算器

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    质量
    =
    浓度
    ×
    体积
    ×
    分子量 *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    浓度 (start)

    C1

    ×
    体积 (start)

    V1

    =
    浓度 (final)

    C2

    ×
    体积 (final)

    V2

    动物实验：

    请根据您的 实验动物和给药方式 选择适当的溶解方案。

    以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液，再依次添加助溶剂：
    ——为保证实验结果的可靠性，澄清的储备液可以根据储存条件，适当保存；体内实验的工作液，建议您现用现配，当天使用；
    以下溶剂前显示的百分比是指该溶剂在您配制终溶液中的体积占比；如在配制过程中出现沉淀、析出现象，可以通过加热和/或超声的方式助溶

    • 方案 一

      请依序添加每种溶剂： 10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: ≥ 1 mg/mL (1.74 mM); 澄清溶液

      此方案可获得 ≥ 1 mg/mL（饱和度未知）的澄清溶液。

      以 1 mL 工作液为例，取 100 μL 10.0 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液 中，混合均匀。

      2 g SBE-β-CD（磺丁基醚 β-环糊精）粉末定容于 10 mL 的生理盐水中，完全溶解至澄清透明。
    动物溶解方案计算器
    请输入动物实验的基本信息：

    给药剂量

    mg/kg

    动物的平均体重

    g

    每只动物的给药体积

    μL

    动物数量

    只
    由于实验过程有损耗，建议您多配一只动物的量
    计算结果
    工作液所需浓度 : mg/mL
    该产品水溶性佳，请具体参考实测 水 / PBS / Saline 中的溶解度数据。
    您所需的储备液浓度超过该产品的实测溶解度，如有需要，请与 MCE 中国技术支持联系。
    纯度 & 产品资料

    纯度: 99.99%

    COA (202 KB) HNMR (266 KB) RP-HPLC (242 KB) LCMS (93 KB)

    产品使用指南 (1538 KB)
    参考文献

    Palbociclib isethionate 相关分类

    完整储备液配制表

    * 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
    储备液的保存方式和期限：-80°C, 1 year; -20°C, 6 months (sealed storage, away from moisture)。-80°C储存时，请在1年内使用， -20°C储存时，请在6个月内使用。

    可选溶剂 浓度 溶剂体积 质量 1 mg 5 mg 10 mg 25 mg
    DMSO / H2O 1 mM 1.7432 mL 8.7160 mL 17.4319 mL 43.5798 mL
    5 mM 0.3486 mL 1.7432 mL 3.4864 mL 8.7160 mL
    10 mM 0.1743 mL 0.8716 mL 1.7432 mL 4.3580 mL
    15 mM 0.1162 mL 0.5811 mL 1.1621 mL 2.9053 mL
    H2O 20 mM 0.0872 mL 0.4358 mL 0.8716 mL 2.1790 mL
    25 mM 0.0697 mL 0.3486 mL 0.6973 mL 1.7432 mL
    30 mM 0.0581 mL 0.2905 mL 0.5811 mL 1.4527 mL
    40 mM 0.0436 mL 0.2179 mL 0.4358 mL 1.0895 mL
    50 mM 0.0349 mL 0.1743 mL 0.3486 mL 0.8716 mL
    60 mM 0.0291 mL 0.1453 mL 0.2905 mL 0.7263 mL
    80 mM 0.0218 mL 0.1089 mL 0.2179 mL 0.5447 mL

    * 备注：如您选择水作为储备液，请稀释至工作液后，再用 0.22 μm 的滤膜过滤除菌后使用。

    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Keywords:

    Palbociclib827022-33-3PD 0332991帕布昔利布杂质74PD0332991PD-0332991CDKCyclin dependent kinaseBreast cancerhepatocellular carcinomaHCCestrogen receptorERHER2cell cycleInhibitorinhibitorinhibit

    您最近查看的产品:

    Your information is safe with us. * Required Fields.

       产品名称：

    		  

    * 需求量：

    * 客户姓名：

    		 

    * Email：

    * 电话：

    		 

    * 公司或机构名称：

       留言给我们：

    Bulk Inquiry

    Inquiry Information

    产品名称：
    Palbociclib isethionate
    目录号：
    HY-A0065
    需求量：

    Request for HNMR Report

    Please fill out this form to request the QC report. We will send it to your Email address shortly.

    Your information is safe with us. * Required Fields.

       产品名称：

    		  

    * Lot #：

    * 客户姓名：

    		 

    * Email：

       电话：

    		 

    * 部门：

    * 公司或机构名称：

    		 

       留言给我们：

    Request for HNMR Report

    We have received your request and will respond to you as soon as possible.

    嗨！很高兴为您提供帮助！

    尊敬的 MCE 客户您好，
    请您选择所在区域，我们将转接对应客服为您服务！

    热门区域

    A

    B

    C

    F

    G

    H

    J

    L

    N

    Q

    S

    T

    X

    Y

    Z

    热 A B C F G H J L N Q S T X Y Z